Nuvation Bio annual total assets
2020
2021
2022
2023
2024
2025
Nuvation Bio Total Assets Growth & History (NUVB)
Nuvation Bio's total assets was $594.8M for fiscal 2025.
View full Nuvation Bio company overviewNuvation Bio annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $594.8M | $54.2M | +10.02% |
| 2024 | 2024-12-31 | $540.6M | −$80.9M | −13.01% |
| 2023 | 2023-12-31 | $621.5M | −$50.7M | −7.54% |
| 2022 | 2022-12-31 | $672.1M | −$104.0M | −13.40% |
| 2021 | 2021-12-31 | $776.2M | $554.4M | +249.95% |
| 2020 | 2020-12-31 | $221.8M | — | — |
Nuvation Bio quarterly total assets
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $744.5M | $97.3M | +15.03% |
| Q1 2026 | 2026-03-31 | $610.2M | $117.8M | +23.91% |
| Q4 2025 | 2025-12-31 | $594.8M | $54.2M | +10.02% |
| Q3 2025 | 2025-09-30 | $601.6M | $30.0M | +5.25% |
| Q2 2025 | 2025-06-30 | $647.2M | $52.4M | +8.81% |
| Q1 2025 | 2025-03-31 | $492.5M | −$120.6M | −19.68% |
| Q4 2024 | 2024-12-31 | $540.6M | −$80.9M | −13.01% |
| Q3 2024 | 2024-09-30 | $571.6M | −$59.3M | −9.40% |
| Q2 2024 | 2024-06-30 | $594.8M | −$46.6M | −7.27% |
| Q1 2024 | 2024-03-31 | $613.1M | −$43.9M | −6.69% |
| Q4 2023 | 2023-12-31 | $621.5M | −$50.7M | −7.54% |
| Q3 2023 | 2023-09-30 | $630.9M | −$55.6M | −8.10% |
| Q2 2023 | 2023-06-30 | $641.4M | −$78.3M | −10.88% |
| Q1 2023 | 2023-03-31 | $657.1M | −$94.7M | −12.60% |
| Q4 2022 | 2022-12-31 | $672.1M | −$104.0M | −13.40% |
| Q3 2022 | 2022-09-30 | $686.5M | −$111.3M | −13.95% |
| Q2 2022 | 2022-06-30 | $719.7M | −$94.5M | −11.61% |
| Q1 2022 | 2022-03-31 | $751.8M | −$80.3M | −9.65% |
| Q4 2021 | 2021-12-31 | $776.2M | $554.4M | +249.95% |
| Q3 2021 | 2021-09-30 | $797.8M | $652.3M | +448.31% |
| Q2 2021 | 2021-06-30 | $814.3M | $814.1M | +475757.17% |
| Q1 2021 | 2021-03-31 | $832.1M | — | — |
| Q4 2020 | 2020-12-31 | $221.8M | — | — |
| Q3 2020 | 2020-09-30 | $145.5M | — | — |
| Q2 2020 | 2020-06-30 | $171,115 | — | — |
Nuvation Bio total assets trends
Over the last five fiscal years, Nuvation Bio's total assets increased from $221.8M to $594.8M, a change of $373.0M. The latest reported quarter, Q2 2026, shows $744.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nuvation Bio source filings ↗